Treatment of Infantile Hemangiomas in Concomitant Tuberous Sclerosis Complex Should Prompt Evaluation for Cardiac Rhabdomyomas Prior to Initiation of Propranolol

Cutis. 2024 Jun;113(6):E14-E16. doi: 10.12788/cutis.1040.

Authors

Maria Gnarra Buethe¹, Antonino Di Franco¹, Laura Uwakwe¹, Sharon A Glick¹

Affiliation

¹ Drs. Uwakwe and Glick are from and Dr. Buethe was from the Department of Dermatology, SUNY Downstate Health Sciences University, Brooklyn, New York. Dr. Buethe currently is from the University of California San Diego/Rady Children's Hospital. Dr. Di Franco is from the Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, New York.

PMID: 39082988
DOI: 10.12788/cutis.1040

No abstract available

Publication types

Letter
Case Reports

MeSH terms

Adrenergic beta-Antagonists / administration & dosage
Adrenergic beta-Antagonists / therapeutic use
Heart Neoplasms* / complications
Heart Neoplasms* / diagnosis
Heart Neoplasms* / drug therapy
Hemangioma* / complications
Hemangioma* / drug therapy
Humans
Infant
Propranolol* / administration & dosage
Propranolol* / therapeutic use
Rhabdomyoma* / complications
Rhabdomyoma* / diagnosis
Rhabdomyoma* / drug therapy
Skin Neoplasms / complications
Skin Neoplasms / diagnosis
Skin Neoplasms / drug therapy
Skin Neoplasms / pathology
Tuberous Sclerosis* / complications

Substances

Adrenergic beta-Antagonists
Propranolol